| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |